October 1, 2021
Friday | 12:00 - 16:00 (GMT+3)

Session I:
Moderators: Goda Elizabeta Vaitkevičienė, Giedrė Rutkauskienė 

12:00 – 12:25

40 Years of Experience in Pediatric Hematology and Oncology in Lithuania

Jelena Rascon, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania

12:25 – 12:50

Achievements in reducing early toxicity for pediatric ALL patients in Lithuania during time periods

Goda Elizabeta Vaitkevičienė, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania

12:50 – 13:10

ALL treatment results in Latvia

Anna Valaine, MD, PhD, Children's Clinical University Hospital, Latvia

13:10– 13:30

Optimization of Treatment Outcomes in Estonian Pediatric AML Population

Kadri Saks, Tallinn Children´s Hospital, Estonia

13:30 – 13:45

Discussion

13:45 – 14:00

Break

Session II

Moderators: Jelena Rascon ir Rosita Kiudelienė

14:00– 14:45

Late complications in childhood cancer survivors and transition from pediatric to adult healthcare

Marianne Jarfelt, MD, PhD, Sahlgrenska University Hospital, Göteborg, Sweden

14:45 – 15:05

Follow-up after childhood cancer treatment

Rūta Maškė, MD, Lithuanian University of Health Sciences

15:05– 15:25

Persistent IDA - what other underlying disease can it mask?

Monika Kapitančukė, MD, Vilnius University Hospital Santaros Klinikos, Lithuania

15:25– 15:45

Relationship between proteinuria and venous thromboembolism?

​Sonata Šaulytė Trakymienė, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania

15:45 – 16:00

Discussion

.